Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Ipratropium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 known ✓ | P20309 | 6/20 | 0.95 |
| ▸ | CHRM2 | P08172 | 7/20 | 0.95 |
| ▸ | CHRM5 | P08912 | 6/20 | 0.95 |
| ▸ | CHRM1 | P11229 | 6/20 | 0.95 |
| ▸ | CHRM4 | P08173 | 5/20 | 0.95 |
| ▸ | MEN1 | O00255 | 3/20 | 0.95 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.95 |
| ▸ | TSHR | P16473 | 2/20 | 0.95 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.91 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.79 |
| ▸ | BLM | P54132 | 4/20 | 0.75 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.73 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.62 |
| ▸ | HTR2C | P28335 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ipratropium SCHEMBL19211133 | 0.99 | CHRM2 (0.98) | CHRM2CHRM5CHRM1CHRM3CHRM4 | |
| Ipratropium SCHEMBL22467689 | 0.99 | CHRM2 (0.98) | CHRM2CHRM5CHRM1CHRM3CHRM4 | |
| Ipratropium SCHEMBL3301405 | 0.99 | CHRM2 (0.98) | CHRM2CHRM5CHRM1CHRM3CHRM4 | |
| Ipratropium SCHEMBL27539194 | 0.99 | CHRM2 (0.98) | CHRM2CHRM5CHRM1CHRM3CHRM4 | |
| Ipratropium SCHEMBL99101 | 0.99 | CHRM2 (0.98) | CHRM2CHRM5CHRM1CHRM3CHRM4 | |
| Ipratropium SCHEMBL25298399 | 0.98 | CHRM2 (0.95) | CHRM2CHRM5CHRM1CHRM3CHRM4 | |
| Ipratropium SCHEMBL7678599 | 0.98 | CHRM2 (0.95) | CHRM2CHRM5CHRM1CHRM3CHRM4 | |
| Ipratropium SCHEMBL6553359 | 0.98 | CHRM2 (0.95) | CHRM2CHRM5CHRM1CHRM3CHRM4 | |
| Ipratropium SCHEMBL22077028 | 0.98 | CHRM2 (0.96) | CHRM2CHRM5CHRM1CHRM3CHRM4 | |
| Ipratropium SCHEMBL17271494 | 0.98 | CHRM2 (0.96) | CHRM2CHRM5CHRM1CHRM3CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3384909-A1 | COMBINATION OF OXYMETAZOLINE AND IPRATROPIUM IN TOPICAL NASAL APPLICATION FOR THE TREATMENT OF A COUGH | Cortés Borrego, Pablo (MX) | 2018-10-10 | — | — | EP | claimed |
| EP-2978407-A1 | AQUEOUS SOLUTION COMPOSITION CONTAINING IPRATROPIUM AND OXYMETAZOLINE | Santa Farma Ilaç Sanayi A.S. (TR) | 2016-02-03 | — | — | EP | claimed |
| WO-2014158119-A1 | AQUEOUS SOLUTION COMPOSITION CONTAINING IPRATROPIUM AND OXYMETAZOLINE | SANTA FARMA İLAÇ SANAYİ A.Ş (TR) | 2014-10-02 | — | — | WO | claimed |
| WO-2014158118-A1 | SUSPENSION COMPOSITION CONTAINING IPRATROPIUM AND OXYMETAZOLINE | SANTA FARMA İLAÇ SANAYİ A.Ş. (TR) | 2014-10-02 | — | — | WO | claimed |
| US-8450339-B2 | Compositions for treatment of common cold | TAKEDA PHARMA A/S (DK) | 2013-05-28 | — | — | US | claimed |
| US-20100093783-A1 | Composition for treatment of common cold | TAKEDA PHARMA A/S (DK) | 2010-04-15 | — | — | US | claimed |
| EP-1661570-A2 | Compositions comprising ipatropium and xylometazoline for treatment of the common cold | Nycomed Danmark ApS (DK) | 2006-05-31 | — | — | EP | claimed |
| EP-1446119-B1 | COMPOSITIONS COMPRISING IPATROPIUM AND XYLOMETAZOLINE FOR TREATMENT OF THE COMMON COLD | NYCOMED DANMARK APS (DK) | 2006-03-01 | — | — | EP | claimed |
| US-20040248924-A1 | Compositions for treatment of common cold | TAKEDA PHARMA A/S (DK) | 2004-12-09 | — | — | US | claimed |
| EP-1446119-A2 | COMPOSITIONS COMPRISING IPATROPIUM AND XYLOMETAZOLINE FOR TREATMENT OF THE COMMON COLD | Nycomed Danmark ApS (DK) | 2004-08-18 | — | — | EP | claimed |
| WO-2003024433-A2 | COMPOSITIONS FOR TREATMENT OF COMMON COLD, COMPRISING IPRATROPIUM AND XYLOMETAZOLINE | NYCOMED DANMARK APS (DK) | 2003-03-27 | — | — | WO | claimed |
| EP-2978407-B1 | AQUEOUS SOLUTION COMPOSITION CONTAINING IPRATROPIUM AND OXYMETAZOLINE | SANTA FARMA ILAC SANAYI A S (TR) | 2020-05-06 | — | — | EP | disclosed |
| US-10391087-B2 | Combination of oxymetazoline and ipratropium in topical nasal application for the treatment of a cough | CORTES BORREGO PABLO (MX) | 2019-08-27 | — | — | US | disclosed |
| US-20180344722-A1 | Combination of Oxymetazoline and Ipratropium in Topical Nasal Application for the Treatment of a Cough | CORTES BORREGO PABLO (MX) | 2018-12-06 | — | — | US | disclosed |
| EP-3384909-A1 | COMBINATION OF OXYMETAZOLINE AND IPRATROPIUM IN TOPICAL NASAL APPLICATION FOR THE TREATMENT OF A COUGH | Cortés Borrego, Pablo (MX) | 2018-10-10 | — | — | EP | disclosed |
| EP-1661570-A2 | Compositions comprising ipatropium and xylometazoline for treatment of the common cold | Nycomed Danmark ApS (DK) | 2006-05-31 | — | — | EP | disclosed |
| EP-1446119-B1 | COMPOSITIONS COMPRISING IPATROPIUM AND XYLOMETAZOLINE FOR TREATMENT OF THE COMMON COLD | NYCOMED DANMARK APS (DK) | 2006-03-01 | — | — | EP | disclosed |
| US-20040248924-A1 | Compositions for treatment of common cold | TAKEDA PHARMA A/S (DK) | 2004-12-09 | — | — | US | disclosed |
| EP-1446119-A2 | COMPOSITIONS COMPRISING IPATROPIUM AND XYLOMETAZOLINE FOR TREATMENT OF THE COMMON COLD | Nycomed Danmark ApS (DK) | 2004-08-18 | — | — | EP | disclosed |
| WO-2003024433-A2 | COMPOSITIONS FOR TREATMENT OF COMMON COLD, COMPRISING IPRATROPIUM AND XYLOMETAZOLINE | NYCOMED DANMARK APS (DK) | 2003-03-27 | — | — | WO | disclosed |